Cite

HARVARD Citation

    Gay, N. et al. (2017). Targeting the programmed cell death 1 pathway in Hodgkin lymphoma: the place of nivolumab. Therapeutic advances in hematology. pp. 175-180. [Online]. 
  
Back to record